Patents by Inventor Cédric Charrier
Cédric Charrier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220372027Abstract: The invention encompasses a new series of antibacterial compounds, compositions containing these compounds, and methods of treating Enterobacteriaceae bacterial diseases and infections using these compounds. The compounds find application in the treatment of infection with, and disease caused by Gram-negative bacteria Enterobacteriaceae species that have developed resistance to existing antibiotics.Type: ApplicationFiled: April 25, 2022Publication date: November 24, 2022Inventors: Paul Meo, Mohammed Nawaz Khan, Cedric Charrier
-
Patent number: 11345694Abstract: The present invention relates to compounds of general formula (II), to compositions comprising these compounds and to methods of treating Enterobacteriaceae bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Enterobacteriaceae.Type: GrantFiled: November 2, 2018Date of Patent: May 31, 2022Assignee: Discuva Ltd.Inventors: Paul Meo, Mohammed Nawaz Khan, Cedric Charrier
-
Publication number: 20210163460Abstract: The present invention relates to compounds of general formula (II), to compositions comprising these compounds and to methods of treating Enterobacteriaceae bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Enterobacteriaceae.Type: ApplicationFiled: November 2, 2018Publication date: June 3, 2021Applicant: DISCUVA LTD.Inventors: Paul MEO, Mohammed Nawaz KHAN, Cedric CHARRIER
-
Patent number: 11020414Abstract: The invention relates to products comprising an antibiotic agent and a second agent being a dispersant or an anti-adhesive agent, in particular a mucolytic dispersant or a mucolytic anti-adhesive agent, which are useful in relation to the prevention and treatment of bacterial infections.Type: GrantFiled: February 11, 2016Date of Patent: June 1, 2021Assignee: NOVABIOTICS LIMITEDInventors: Deborah O'Neil, Cedric Charrier
-
Publication number: 20190175528Abstract: The present invention relates to a product comprising at least two antibiofilm agents wherein at least one of the antibiofilm agents is an antimicrobial peptide. The second antibiofilm agent is cysteamine. There is also provided the use of the product in the treatment of a microbial infection.Type: ApplicationFiled: February 13, 2019Publication date: June 13, 2019Inventors: Deborah O'Neil, Derry Mercer, Cedric Charrier
-
Patent number: 9782423Abstract: The invention relates to products comprising an antibiotic agent and a second agent being a dispersant or an anti-adhesive agent, in particular a mucolytic dispersant or a mucolytic anti-adhesive agent, which are useful in relation to the prevention and treatment of bacterial infections.Type: GrantFiled: June 1, 2012Date of Patent: October 10, 2017Assignee: Novabiotics LimitedInventors: Deborah O'Neil, Cedric Charrier
-
Publication number: 20160206575Abstract: The present invention relates to a product comprising at least two antibiofilm agents wherein at least one of the antibiofilm agents is an antimicrobial peptide. The second antibiofilm agent is cysteamine. There is also provided the use of the product in the treatment of a microbial infection.Type: ApplicationFiled: March 28, 2016Publication date: July 21, 2016Applicant: NOVABIOTICS LIMITEDInventors: Deborah O'NEIL, Derry MERCER, Cedric CHARRIER
-
Patent number: 9364491Abstract: The invention relates to products comprising an antibiotic agent and a second agent being a dispersant or an anti-adhesive agent, in particular a mucolytic dispersant or a mucolytic anti-adhesive agent, which are useful in relation to the prevention and treatment of bacterial infections.Type: GrantFiled: August 15, 2014Date of Patent: June 14, 2016Assignee: NOVABIOTICS LIMITEDInventors: Deborah O'Neil, Cedric Charrier
-
Publication number: 20160158169Abstract: The invention relates to products comprising an antibiotic agent and a second agent being a dispersant or an anti-adhesive agent, in particular a mucolytic dispersant or a mucolytic anti-adhesive agent, which are useful in relation to the prevention and treatment of bacterial infections.Type: ApplicationFiled: February 11, 2016Publication date: June 9, 2016Applicant: NOVABIOTICS LIMITEDInventors: Deborah O'NEIL, Cedric CHARRIER
-
Patent number: 9339525Abstract: The present invention relates to a product comprising at least two antibiofilm agents wherein at least one of the antibiofilm agents is an antimicrobial peptide. The second antibiofilm agent is cysteamine. There is also provided the use of the product in the treatment of a microbial infection.Type: GrantFiled: March 31, 2010Date of Patent: May 17, 2016Assignee: Novabiotics LimitedInventors: Deborah O'Neil, Derry Mercer, Cedric Charrier
-
Patent number: 9021016Abstract: A method, apparatus and system for managing communications between a client machine and a mobile computing device. The mobile computing device comprising: a storage configured to maintain a host application; a processor configured to execute the host application; an interface configured to connect to the client machine, the interface further configured to carry a web request from the client machine to the processor, the host application configured to respond to the web request.Type: GrantFiled: August 5, 2011Date of Patent: April 28, 2015Assignees: BlackBerry Limited, 2236008 Ontario Inc.Inventors: Edward Snow Willis, Ennis Al-Asaaed, Michael Ian Clough, Cédric Charrier, Timothy Richard Tyhurst, George Dos Santos, Aleksandar Ristovski, Sean Derek Boudreau
-
Publication number: 20140357592Abstract: The invention relates to products comprising an antibiotic agent and a second agent being a dispersant or an anti-adhesive agent, in particular a mucolytic dispersant or a mucolytic anti-adhesive agent, which are useful in relation to the prevention and treatment of bacterial infections.Type: ApplicationFiled: August 15, 2014Publication date: December 4, 2014Applicant: NOVABIOTICS LIMITEDInventors: Deborah O'NEIL, Cedric CHARRIER
-
Patent number: 8901071Abstract: The present invention relates to peptides and their use in the treatment of microbial infections, in particular bacterial infections. In particular, the invention relates to peptides wherein at least 75% of the amino acids of the peptide are arginine and phenylalanine amino acids, at least 50% of the amino acids being arginine amino acids and at least 15% of the amino acids being phenylalanine amino acids.Type: GrantFiled: March 30, 2011Date of Patent: December 2, 2014Assignee: Novabiotics LimitedInventors: Deborah O'Neil, Derry Mercer, Cedric Charrier
-
Publication number: 20130102524Abstract: The present invention relates to peptides and their use in the treatment of microbial infections, in particular bacterial infections. In particular, the invention relates to peptides wherein at least 75% of the amino acids of the peptide are arginine and phenylalanine amino acids, at least 50% of the amino acids being arginine amino acids and at least 15% of the amino acids being phenylalanine amino acids.Type: ApplicationFiled: March 30, 2011Publication date: April 25, 2013Applicant: Novabiotics LimitedInventors: Deborah O'Neil, Derry Mercer, Cedric Charrier
-
Publication number: 20120328671Abstract: The invention relates to products comprising an antibiotic agent and a second agent being a dispersant or an anti-adhesive agent, in particular a mucolytic dispersant or a mucolytic anti-adhesive agent, which are useful in relation to the prevention and treatment of bacterial infections.Type: ApplicationFiled: June 1, 2012Publication date: December 27, 2012Applicant: NOVABIOTICS LIMITEDInventors: Deborah O'Neil, Cedric Charrier
-
Publication number: 20120189682Abstract: The present invention relates to a product comprising at least two antibiofilm agents wherein at least one of the antibiofilm agents is an antimicrobial peptide. The second antibiofilm agent is generally a dispersant or an anti-adhesive agent. There is also provided the use of the product in the treatment of a microbial infection.Type: ApplicationFiled: March 31, 2010Publication date: July 26, 2012Applicant: Novabiotics LimitedInventors: Deborah O'Neil, Derry Mercer, Cedric Charrier
-
Publication number: 20120079006Abstract: A method, apparatus and system for managing communications between a client machine and a mobile computing device. The mobile computing device comprising: a storage configured to maintain a host application; a processor configured to execute the host application; an interface configured to connect to the client machine, the interface further configured to carry a web request from the client machine to the processor, the host application configured to respond to the web request.Type: ApplicationFiled: August 5, 2011Publication date: March 29, 2012Applicants: QNX Software Systems, Research In Motion LimitedInventors: Willis Edward Snow, Ennis Al-Asaaed, Michael Ian Clough, Cédric Charrier, Timothy Richard Tyhurst, George Dos Santos, Aleksandar Ristovski, Sean Derek Boudreau